Headline
The latest stories from AHA Today.
The House of Representatives passed by unanimous consent legislation (S. 4116) extending the Paycheck Protection Program loan application period through Aug. 8.
The Federal Communications Commission’s Rural Health Care Program will carry forward up to $197.98 million in unused funds from prior years to increase available funding for 2020 to $802.74 million if needed, the agency announced.
Oklahoma voters approved expanding the state’s Medicaid initiative, the first state to do so during the COVID-19 pandemic. The ballot question, which passed with nearly 50.5% of the vote, initiates a state constitutional amendment to provide Medicaid to those with incomes at or below 138% of the…
A bipartisan group of senators introduced the Lifting Our Communities through Advance Liquidity for Infrastructure Act, AHA-supported legislation that would restore tax exemption for advance refunding bonds.
The Food and Drug Administration issued guidance for the development of a SARS-CoV-2 vaccine, outlining key considerations to satisfy requirements for chemistry, manufacturing and control, nonclinical and clinical data.
The Department of Health and Human Services announced the reestablishment of the Ready Reserve Corps, a uniformed services that provides trained and ready personnel available on short notice to fill critical public health needs.
Hospitals face a triple threat with financial losses due to COVID-19, AHA President and CEO said on CNBC.
The Senate passed by unanimous consent legislation (S. 4116) extending the Paycheck Protection Program loan application period through Aug. 8. It’s unclear if the House will take up the legislation before the July 4th recess.
In light of the COVID-19 pandemic, the AHA has suspended three award programs that entail site visits to finalist organizations for 2021: the AHA Quest for Quality Prize; the Circle of Life Award: Celebrating Innovation in Palliative and End-of-Life Care; and the Foster G. McGaw Prize for…
The Food and Drug Administration authorized the emergency use of two COVID-19 molecular diagnostic tests. The tests from Inform Diagnostics Inc. and Diagnostic Solutions Laboratory LLC detect in respiratory specimens nucleic acid from SARS-CoV-2, the virus that causes COVID-19.